BioSpace News Archive

GENOMICA, PharmaMar Group, is developing a kit to detect the new Wuhan coronavirus

GENOMICA, a wholly owned company of PharmaMar Group, is developing a kit to reliably detect and identify the new virus known as “Wuhan pneumonia”.

February 3, 2020

·

4 min read

PhoreMost announces two key appointments to strengthen leadership team

Business

PhoreMost strengthens leadership team with two key appointments

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has made two appointments to strengthen its leadership team, as the Company positions itself for growth.

February 3, 2020

·

3 min read

RauCon Pharma Partnering Conferences Limit Attendance For More Value

RauCon has now introduced limits to the number of participants of its euroPLX and asiaPLX Pharma Partnering Conferences in order to increase their value for the individual participant.

February 3, 2020

·

1 min read

Pharm Country

Siemens Healthineers Wins Bid to Become Primary Supplier for Quest Diagnostics Immunoassay Testing with Atellica Solution

Quest plans to standardize its immunoassay testing across 19 core laboratories, including a new flagship lab in Clifton, New Jersey with Atellica Solution and automation

February 3, 2020

·

4 min read

A Revolution in Laparoscopic Training: KARL STORZ and VirtaMed Leap Beyond VR Simulation

KARL STORZ, the leading endoscopy manufacturer, and VirtaMed, world leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.

February 3, 2020

·

4 min read

Policy

GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma

Belantamab mafodotin accepted for accelerated assessment by the EMA’s Committee for Human Medicinal Products (CHMP)

February 3, 2020

·

7 min read

Biotech Beach

Calidi Biotherapeutics Announces Abstract Acceptance for Presentation at the ASCO-SITC Clinical Immuno-Oncology Symposium

Calidi Biotherapeutics, Inc. announced the acceptance of an abstract for presentation at the ASCO-SITC Clinical Immuno-Oncology Symposium, which is being held February 6 to February 8, 2020, at the Rosen Shingle Creek Resort in Orlando, Florida.

February 3, 2020

·

3 min read

Job Trends

Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France

Rubraca® (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with relapsed, platinum-sensitive ovarian cancer, who harbor either a BRCA1/2 mutation or are BRCA wild-type

February 3, 2020

·

11 min read

Policy

Mesoblast Submits Completed Biologics License Application for Ryoncil™ to US FDA

Mesoblast Limited announced that it has submitted its completed Biologics License Application to the United States Food and Drug Administration for Ryoncil™, its lead allogeneic cell therapy for the treatment of children with steroid-refractory acute graft versus host disease.

February 3, 2020

·

5 min read

Biotech Beach

ChromaDex Launches New Line of High Purity Cannabinoid (CBD) Reference Standards Available for Research and Analytical Testing WorldwideChromaDex launches new research tools for the CBD industry with line of reference standards

ChromaDex Corp. announced the expansion of its industry-leading reference standards business with a new line of cannabinoid reference standards available to researchers across the globe.

February 3, 2020

·

3 min read